|
⚲
|
| Keyboard |
| Gellert Michael E
✚
|
|
|---|---|
| CIK # | 0001018650 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001018650] | |
| 4 | [0001018650] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Gellert Michael E | |
| Apellis Pharmaceuticals Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Apellis Pharmaceuticals Inc APLS
Common Stock
|
2017-11-13 | Conversion | 798,068 | ||
|
Apellis Pharmaceuticals Inc APLS
Series B Preferred Stock · derivative
|
2017-11-13 | Conversion | 545,454 | $0.00 | |
|
Apellis Pharmaceuticals Inc APLS
Series A Preferred Stock · derivative
|
2017-11-13 | Conversion | 600,000 | $0.00 | |
|
Apellis Pharmaceuticals Inc APLS
Series C Preferred Stock · derivative
|
2017-11-13 | Conversion | 556,830 | $0.00 |